EVALUATING THE COST-EFFECTIVENESS OF VOCLOSPORIN IN THE UNITED STATES FOR THE TREATMENT OF LUPUS NEPHRITIS

被引：0
|
作者：
Flauto, Ronald [2 ]
Lee, Ernie [1 ]
Atencio, Victoria [2 ]
Birardi, Vanessa [2 ]
Kennedy, Lisa [1 ]
机构：
[1] Innopiphany, Victoria, BC, Canada
[2] Aurinia Pharmaceut Inc, Vancouver, BC, Canada
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2024年 / 83卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
369
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [31] The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States
    Messali, Andrew
    Hay, Joel W.
    Villacorta, Reginald
    NEURO-ONCOLOGY, 2013, 15 (11) : 1532 - 1542
  • [32] Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States
    Jia, Xiaoying
    Zhao, Yang
    Carrico, Justin
    Brodtkorb, Thor-Henrik
    Mendelsohn, Alan M.
    Lowry, Simon
    Feldman, Steve
    Wu, Jashin J.
    Armstrong, April W.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 740 - 748
  • [33] COST-EFFECTIVENESS ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES
    Hernandez, L. G.
    Li, S.
    Toro-Diaz, H.
    Zhang, Q.
    Sheehan, J.
    Le, H.
    VALUE IN HEALTH, 2019, 22 : S228 - S229
  • [34] Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States
    Chirikov, Viktor
    Ma, Ingrid
    Joshi, Namita
    Patel, Dipen
    Smith, Alden
    Giambrone, Cindy
    Cornelio, Noelle
    Hashemi, Lobat
    VALUE IN HEALTH, 2019, 22 (02) : 168 - 176
  • [35] Cost-effectiveness of treatment with entacapone for patients with Parkinson's disease in the United States
    Palmer, C
    Nuijten, M
    Schmier, J
    Subedi, P
    Snyder, E
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 496 - 496
  • [36] COST-EFFECTIVENESS OF CONJUGATED ESTROGENS/BAZEDOXIFENE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN THE UNITED STATES
    Teitsson, S.
    Bobula, J.
    Hawes, C.
    Moffatt, M.
    Ohna, A.
    Borgstrom, F.
    VALUE IN HEALTH, 2015, 18 (07) : A736 - A736
  • [37] MODELING THE COST-EFFECTIVENESS OF BORTEZOMIB FOR THE INITIAL TREATMENT OF MULTIPLE MYELOMA IN THE UNITED STATES
    Wang, S. T.
    Huang, H.
    Shi, H.
    Duh, M. S.
    Chen, K.
    Chang, E.
    Korves, C.
    Dhawan, R.
    Cakana, A.
    Van de Velde, H.
    Esseltine, D. L.
    Garrison, L.
    VALUE IN HEALTH, 2010, 13 (03) : A210 - A210
  • [38] Cost-effectiveness of percutaneous treatment of iliac artery occlusive disease in the United States
    Bosch, JL
    Haaring, C
    Meyerovitz, MF
    Cullen, KA
    Hunink, MGM
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 175 (02) : 517 - 521
  • [39] Cost-effectiveness of Ivabradine as a Treatment for Systolic Chronic Heart Failure in the United States
    Kansal, Anuraag R.
    Cowie, Martin
    Kielhorn, Adrian
    Krotneva, Stanimira
    Taffazzoli, Ali
    Zheng, Ying
    Yurgin, Nicole
    CIRCULATION, 2015, 132
  • [40] THE COST-EFFECTIVENESS OF TEMOZOLOMIDE IN THE ADJUVANT TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA IN THE UNITED STATES
    Messali, A.
    Hay, J.
    Villacorta, R.
    VALUE IN HEALTH, 2012, 15 (04) : A221 - A222
12345